A randomized phase III, double-blinded, placebo-controlled trial of aspirin as adjuvant therapy for breast cancer (A011502): The Aspirin after Breast Cancer (ABC) Trial

Abstract

360922

Document Details

• Document Type: Pub Defense Publication
• Publication Date: Apr 20, 2022
• Source ID: 10.1200/jco.2022.40.36_suppl.360922

Entities

People

• Ann Partridge
• Anna Weiss
• Carol Matyka
• Eric Winer
• Frederick M. Briccetti
• Karla V. Ballman
• Linda Mackie Mccall
• Lisa A Carey
• Margaret Carvan
• Michelle D Holmes
• Olwen Mary Hahn
• Paula R. Pohlmann
• Thomas H. Openshaw
• Wendy Y. Chen
• William Johnson Irvin

Organizations

• Alliance for Clinical Trials in Oncology
• Brigham and Women's Hospital
• Dana–Farber Cancer Institute
• Georgetown Lombardi Comprehensive Cancer Center
• Harvard Medical School
• National Breast Cancer Coalition
• National Institutes of Health
• United States Department of Defense
• University of Chicago
• University of North Carolina
• Weill Cornell Medicine